$266.92 0.6%
Price vs. AI Score (Last 150 days)
Data gathered: November 29

Data Bits

Data Bits Value / Change Benchmark
Job Posts 599 -0.2%
Sentiment 96 0%
Webpage traffic 316,000 18.4%
Employee Rating 83 0%
Google Adspend $ N/A N/A
Google Trends 33 -50.7%
Linkedin Employees 31,915 N/A
Lobbying Cost $1,130,000 0%
Patents 1,037 0.4%
4chan Mentions 0%
Facebook Engagement 75 -7.4%
Facebook followers 31,757 0%
Stocktwits Mentions 4 -20%
Stocktwits Subscribers 12,959 0%
Twitter Followers 122,897 0%
Youtube Subscribers 32,100 0%
Instagram Followers 22,970 0%
News Mentions 1 0%
Reddit Mentions 0%
ESG 76 0%
Business outlook 74 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Amgen

Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.

Price $266.92
Target Price Sign up
Market Cap $142B
Dividend Yield 0.0321
Industry Biotechnology

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '236.33B3.88B2.44B1.73B3.4B
Q2 '236.35B3.84B2.51B1.38B3.06B
Q1 '235.68B3.67B2B2.84B4.68B
Q4 '2278M4.02B78M1.62B2.86B
Q3 '226.36B3.5B2.86B2.14B3.39B

Insider Transactions

Graham Jonathan P filed to sell 28,078 shares at $272.8.
November 13 '23
Gordon Murdo filed to sell 44,308 shares at $262.4.
August 11 '23
Khosla Rachna filed to sell 6,630 shares at $292.9.
November 10 '22
Grygiel Nancy A. filed to sell 13,009 shares at $293.5.
November 8 '22
Williams R Sanders filed to sell 5,301 shares at $250.
August 22 '22
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.